⌘K

Home/Filings/4/0000875320-25-000124

4//SEC Filing

Arbuckle Stuart A 4

Accession 0000875320-25-000124

CIK 0000875320other

View on SEC.gov Company Profile

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 4:31 PM ET

Size

5.2 KB

Accession

0000875320-25-000124

Insider Transaction Report

Form 4

Period: 2025-02-26

VERTEX PHARMACEUTICALS INC / MAVRTX

Arbuckle Stuart A

EVP\Chief Commercial Officer

Transactions

Tax Payment
Common Stock
2025-02-26$479.61/sh−7,071$3,391,322→ 62,935 total

Holdings

Common Stock
(indirect: By 401(k))
140

Documents

1 file

4
wk-form4_1740778255.xmlPrimary
FORM 4

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1

filerCIK 0001557290

Filing Metadata

Form type: 4
Filed: Feb 27, 7:00 PM ET
Accepted: Feb 28, 4:31 PM ET
Size: 5.2 KB

View on SEC.gov